Loading...
Loading...
Merrimack Pharmaceuticals Inc
MACK shares rose 0.6% to $5.53 after the company revealed that the ONIVYDE regimen has received a positive CHMP Opinion in the European Union. Share volume was 463,000, compared to an all-day average of 1.7 million
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in